Chemical Biology Approaches to Target Protein Modification in Disease Megan Wright, Imperial College London, speaking at Discovery Chemistry Congress 2013.
Guiding Treatment Decisions in Cancer using Protein Biomarker Measurements: from Design to Utility Prof. Stephen Pennington, University College Dublin, speaking at Discovery Chemistry Congress 2013.
Chemical Proteomics: Drug Targets, Drug Selectivity, MoA and Resistance Dr. Guillaume Médard, Technische Universität München, speaking at Discovery Chemistry Congress 2013.
Typical Phospho-form Abundance Profile of Cellular ERK Discovered by Quantitative UPLC-MS Wolf Lehmann, German Cancer Research Center, speaking at Systems Biology Europe 2012
Proteomic and Bioinformatic Approaches to the Development of Biomarker Signatures of Clinical Utility for Prostate Cancer: From Discovery to Targeted Verification Stephen Pennington, University College Dublin, speaking at Systems Biology Europe 2012
In vivo SILAC-based Proteomics Reveals Phosphoproteome Changes during Skin Carcinogenesis Sara Zanivan, Beatson Institute for Cancer Research, speaking at Systems Biology Europe 2012
Kinase Centric Chemical Proteomics Provides Novel Insights into Individual Cancer Biology Bernhard Kuster, Technical University Munich, speaking at Systems Biology Europe 2012
Next Generation X-Aptamers for Identification of Personalized Biomarkers in Cancer David G. Gorenstein, Ph.D., University of Texas Health Sciences Center, speaking at Genomics Research 2012.
Multi-analyte Procedures for Target Screening and Quantification of Drugs in Blood using LC-MS/MS: Possibilities and Limitations Hans Maurer, Saarland University, speaking at European Lab Automation 2012.